Ibrutinib in Treating Patients With Relapsed or Refractory Transformed Indolent B-cell Non-Hodgkin Lymphoma
Clinical trial NCT02207062 · COMPLETED
Trial details
- NCT number
- NCT02207062
- Sponsor
- University of Washington
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2023-11-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.